Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 3

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Hypoactive Delirium 1Cancer Diagnosis 1Breast Neoplasms 1

Interventions

pembrolizumab 1262Specimen Handling 924Magnetic Resonance Spectroscopy 829Carboplatin 821Cyclophosphamide 799Cisplatin 722Nivolumab 667Paclitaxel 627Radiotherapy 608Gemcitabine 570Biopsy 557Bevacizumab 478Dexamethasone 437fludarabine 407Docetaxel 377venetoclax 367Oxaliplatin 364Capecitabine 355Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 329Drug Therapy 325Doxorubicin 316Radiosurgery 314Standard of Care 309Blood Specimen Collection 308Pemetrexed 304Ipilimumab 298Radiation 285

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Health Personnel × 1 year × Clear all
NCT05837039 2026-03-04

A Comparison of Healthcare Provider and Caregiver Perception of Discomfort in Advanced Cancer Patients Who Have a Hypoactive Delirium

M.D. Anderson Cancer Center

Recruiting
100 enrolled

Hypoactive Delirium

NCT07416513 2026-02-18

ALTHEA

European Institute of Oncology

Phase NA Recruiting
200 enrolled

Cancer Diagnosis

NCT06762496 2025-11-28

A New Tool to Promote Patient's Engagement in Their Healthcare Process

European Institute of Oncology

Recruiting
180 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡